Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Bolni Nagalo

Concepts (213)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Blood Donors
11
2021
32
3.830
Why?
Hepatitis B
8
2023
23
2.060
Why?
Oncolytic Virotherapy
3
2022
18
1.650
Why?
HIV Infections
11
2021
352
1.550
Why?
Hepatitis B Surface Antigens
4
2018
9
1.480
Why?
Syphilis
7
2019
27
1.290
Why?
Liver Neoplasms
6
2025
327
1.260
Why?
Carcinoma, Hepatocellular
5
2025
196
1.180
Why?
Hepatitis C
5
2021
80
1.110
Why?
Blood Transfusion
3
2021
129
1.110
Why?
Seroepidemiologic Studies
10
2021
48
0.880
Why?
Burkina Faso
16
2023
16
0.870
Why?
Vesicular Stomatitis
1
2022
1
0.810
Why?
Enzyme-Linked Immunosorbent Assay
4
2018
234
0.740
Why?
Biliary Tract Neoplasms
4
2022
9
0.720
Why?
HIV Antibodies
1
2018
10
0.630
Why?
Blood-Borne Pathogens
1
2018
7
0.620
Why?
HIV-1
4
2018
54
0.570
Why?
Gabon
4
2019
4
0.510
Why?
Mass Screening
1
2018
344
0.490
Why?
Hepatitis B virus
3
2025
26
0.440
Why?
Rural Population
1
2018
555
0.440
Why?
Young Adult
11
2021
4107
0.440
Why?
Skin Neoplasms
3
2024
491
0.420
Why?
Humans
37
2025
50516
0.420
Why?
HIV Seroprevalence
2
2014
4
0.410
Why?
Vesiculovirus
2
2022
6
0.410
Why?
Bile Duct Neoplasms
2
2022
27
0.390
Why?
Cholangiocarcinoma
2
2022
25
0.390
Why?
Adult
17
2025
13584
0.380
Why?
Adolescent
10
2021
6446
0.370
Why?
Antibodies, Viral
1
2011
93
0.370
Why?
Communicable Diseases
1
2011
52
0.360
Why?
Plasma
1
2011
46
0.360
Why?
Polymorphism, Single Nucleotide
2
2025
474
0.330
Why?
Melanoma
2
2024
280
0.320
Why?
Female
18
2025
27086
0.280
Why?
Middle Aged
13
2025
12613
0.280
Why?
Prevalence
6
2018
971
0.280
Why?
Male
15
2025
25913
0.270
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2022
1000
0.270
Why?
Cell Line, Tumor
4
2024
1398
0.270
Why?
Antineoplastic Agents
3
2024
1172
0.260
Why?
Sensitivity and Specificity
2
2018
861
0.260
Why?
Hepacivirus
2
2018
105
0.250
Why?
Hepatitis B, Chronic
1
2025
17
0.240
Why?
Cell Proliferation
4
2024
985
0.240
Why?
Extracellular Matrix Proteins
1
2025
68
0.230
Why?
Molecular Docking Simulation
2
2023
73
0.230
Why?
Animals
7
2024
13124
0.220
Why?
Monophenol Monooxygenase
1
2023
5
0.220
Why?
Incidence
2
2021
1032
0.220
Why?
Carcinoma, Pancreatic Ductal
1
2024
31
0.220
Why?
Anti-HIV Agents
2
2014
42
0.220
Why?
Drug Synergism
2
2021
151
0.210
Why?
Psoriasis
1
2023
27
0.200
Why?
Doxorubicin
1
2024
236
0.200
Why?
Dermatitis
1
2023
35
0.200
Why?
Vesicular stomatitis Indiana virus
1
2022
2
0.200
Why?
Antioxidants
2
2023
239
0.200
Why?
Mice
5
2024
5687
0.200
Why?
Pancreatic Neoplasms
1
2024
206
0.180
Why?
Students, Medical
1
2023
162
0.180
Why?
Treponema pallidum
2
2018
10
0.180
Why?
Flavonols
1
2020
2
0.180
Why?
Viral Proteins
1
2022
153
0.180
Why?
Risk Factors
4
2020
3723
0.180
Why?
Disease Models, Animal
2
2023
1436
0.180
Why?
Cymbopogon
1
2020
1
0.170
Why?
Oils, Volatile
1
2020
12
0.170
Why?
Immunotherapy
2
2021
235
0.170
Why?
Protein Kinase Inhibitors
1
2021
204
0.170
Why?
Sequence Deletion
1
2020
67
0.170
Why?
Receptors, KIR
1
2019
13
0.170
Why?
Genotype
4
2025
532
0.170
Why?
Plasma Membrane Calcium-Transporting ATPases
1
2019
2
0.160
Why?
Glutathione Transferase
1
2020
172
0.160
Why?
Polymorphism, Genetic
1
2020
180
0.160
Why?
Retrospective Studies
6
2022
6264
0.160
Why?
Gene Frequency
3
2025
96
0.160
Why?
Virology
1
2018
7
0.160
Why?
Genetic Predisposition to Disease
4
2025
510
0.160
Why?
Anti-Inflammatory Agents
1
2020
163
0.160
Why?
HIV
1
2018
25
0.150
Why?
Aged
6
2022
9743
0.150
Why?
Molecular Structure
3
2024
296
0.150
Why?
Case-Control Studies
4
2025
1155
0.150
Why?
Immunotherapy, Adoptive
1
2018
163
0.130
Why?
Blood Pressure
1
2019
531
0.130
Why?
Odds Ratio
1
2018
551
0.130
Why?
T-Lymphocytes
1
2018
325
0.130
Why?
Polymerase Chain Reaction
2
2014
449
0.130
Why?
Cross-Sectional Studies
2
2018
1608
0.130
Why?
Cisplatin
3
2022
286
0.120
Why?
HIV-2
1
2014
1
0.120
Why?
Hospitals, Military
1
2014
7
0.120
Why?
Time Factors
2
2018
2935
0.120
Why?
Antibodies, Monoclonal
1
2018
462
0.120
Why?
RNA, Viral
2
2014
107
0.120
Why?
Drug Monitoring
1
2014
79
0.120
Why?
Syphilis Serodiagnosis
1
2014
4
0.110
Why?
Peritonitis
1
2014
25
0.110
Why?
Community-Acquired Infections
1
2014
39
0.110
Why?
Immunocompromised Host
1
2014
119
0.110
Why?
Viremia
1
2014
22
0.110
Why?
Neoplasms
1
2023
1255
0.110
Why?
Alleles
2
2025
255
0.110
Why?
Meningitis, Bacterial
1
2013
6
0.100
Why?
Infectious Disease Transmission, Vertical
1
2012
15
0.100
Why?
Rubella
1
2012
4
0.100
Why?
Antiretroviral Therapy, Highly Active
1
2012
32
0.100
Why?
Toxoplasmosis
1
2012
15
0.100
Why?
Antibodies, Protozoan
1
2012
12
0.100
Why?
Bacteria
1
2014
218
0.100
Why?
Pilot Projects
2
2013
699
0.100
Why?
Bile Ducts, Intrahepatic
2
2022
13
0.100
Why?
Real-Time Polymerase Chain Reaction
1
2013
181
0.100
Why?
Drug Screening Assays, Antitumor
2
2024
131
0.100
Why?
Apoptosis
3
2024
1097
0.100
Why?
TOR Serine-Threonine Kinases
2
2023
78
0.090
Why?
Liver Cirrhosis
2
2025
229
0.090
Why?
Pregnancy Complications, Infectious
1
2012
75
0.090
Why?
Structure-Activity Relationship
2
2024
395
0.090
Why?
Deoxycytidine
2
2021
30
0.090
Why?
Hospitals, Teaching
1
2011
54
0.090
Why?
Autophagy
2
2023
170
0.090
Why?
Tumor Microenvironment
2
2024
222
0.090
Why?
Xenograft Model Antitumor Assays
2
2021
212
0.090
Why?
Cohort Studies
2
2025
1452
0.080
Why?
Programmed Cell Death 1 Receptor
2
2021
39
0.080
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2011
572
0.080
Why?
Tumor Cells, Cultured
2
2020
457
0.080
Why?
Prospective Studies
2
2012
2378
0.080
Why?
Anti-Bacterial Agents
1
2014
745
0.080
Why?
Ionic Liquids
1
2024
1
0.060
Why?
Ablation Techniques
1
2024
22
0.060
Why?
Hydrogels
1
2024
17
0.060
Why?
Delayed-Action Preparations
1
2024
56
0.060
Why?
rho-Associated Kinases
1
2024
20
0.060
Why?
Hedgehog Proteins
1
2024
32
0.060
Why?
Blood Banks
2
2014
17
0.060
Why?
Azoles
1
2023
27
0.050
Why?
Immunomodulation
1
2024
36
0.050
Why?
Rabbits
1
2024
372
0.050
Why?
HLA-DRB1 Chains
1
2023
5
0.050
Why?
Research
1
2023
106
0.050
Why?
HLA Antigens
1
2023
52
0.050
Why?
Interleukin-17
1
2023
37
0.050
Why?
Pyrazoles
1
2023
111
0.050
Why?
Computer Simulation
1
2023
279
0.050
Why?
Medical Oncology
1
2023
99
0.050
Why?
Sirolimus
1
2023
62
0.050
Why?
Platinum
1
2022
11
0.050
Why?
Clone Cells
1
2022
70
0.050
Why?
Proto-Oncogene Proteins c-akt
1
2023
156
0.050
Why?
Phosphatidylinositol 3-Kinases
1
2023
140
0.050
Why?
Cyclin-Dependent Kinase 6
1
2021
2
0.050
Why?
Cyclin-Dependent Kinase 4
1
2021
11
0.050
Why?
Program Evaluation
1
2023
349
0.050
Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2021
11
0.050
Why?
Pregnancy
3
2014
2451
0.050
Why?
Enzyme Inhibitors
1
2023
377
0.050
Why?
Cyclin-Dependent Kinase 2
1
2020
13
0.050
Why?
Proto-Oncogene Proteins c-kit
1
2020
34
0.040
Why?
Curriculum
1
2023
400
0.040
Why?
Cytidine Monophosphate
1
2020
1
0.040
Why?
Flame Ionization
1
2020
3
0.040
Why?
Medicine, Traditional
1
2020
19
0.040
Why?
Mice, Inbred NOD
1
2020
91
0.040
Why?
Plant Leaves
1
2020
40
0.040
Why?
Gas Chromatography-Mass Spectrometry
1
2020
68
0.040
Why?
Mice, SCID
1
2020
178
0.040
Why?
Aldehydes
1
2020
82
0.040
Why?
Cytokines
1
2023
606
0.040
Why?
Genomics
1
2021
279
0.040
Why?
Lipids
1
2020
152
0.040
Why?
DNA, Viral
1
2019
136
0.040
Why?
Sesquiterpenes
1
2020
88
0.040
Why?
Cell Survival
1
2020
589
0.040
Why?
Immunohistochemistry
1
2021
957
0.040
Why?
Genetic Association Studies
1
2019
119
0.040
Why?
CTLA-4 Antigen
1
2018
23
0.040
Why?
Inflammation
1
2023
610
0.040
Why?
Alcohol Drinking
1
2020
227
0.040
Why?
Rats
1
2024
3292
0.040
Why?
Neoplasm Recurrence, Local
1
2021
629
0.040
Why?
Dose-Response Relationship, Drug
1
2020
1372
0.030
Why?
Signal Transduction
1
2024
1624
0.030
Why?
Body Mass Index
1
2020
677
0.030
Why?
Phenotype
1
2019
739
0.030
Why?
Smoking
1
2020
507
0.030
Why?
CD4 Lymphocyte Count
1
2014
32
0.030
Why?
Aged, 80 and over
1
2022
3227
0.030
Why?
Risk Assessment
1
2019
1269
0.030
Why?
Opportunistic Infections
1
2014
57
0.030
Why?
Reagent Kits, Diagnostic
1
2014
17
0.030
Why?
Genotyping Techniques
1
2014
20
0.030
Why?
Hepatitis C Antibodies
1
2014
19
0.030
Why?
Donor Selection
1
2014
18
0.030
Why?
Drug Resistance, Bacterial
1
2014
72
0.030
Why?
Drug Therapy, Combination
1
2014
384
0.030
Why?
Weight Gain
1
2014
237
0.030
Why?
Microbial Sensitivity Tests
1
2014
269
0.030
Why?
Pregnancy Complications, Parasitic
1
2012
4
0.030
Why?
Antibodies, Anti-Idiotypic
1
2012
25
0.030
Why?
Molecular Diagnostic Techniques
1
2013
33
0.030
Why?
Water
1
2012
76
0.020
Why?
Disease Progression
1
2014
829
0.020
Why?
Comorbidity
1
2014
623
0.020
Why?
Socioeconomic Factors
1
2012
591
0.020
Why?
Follow-Up Studies
1
2014
2242
0.020
Why?
Treatment Outcome
1
2014
5285
0.010
Why?
Child
1
2012
6910
0.010
Why?
Nagalo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description